To assess whether temperature is increased by medroxyprogesterone (MPA) and thus whether basal temperature records could be used to determine ovulation during cyclic MPA therapy.
Design
A 2-month double-blind placebo-controlled crossover trial in which oral basal temperature was measured daily.
Setting
Normal human volunteers in an academic medical environment.
Subjects
Eleven postmenopausal women not taking gonadal hormones.
Intervention
Medroxyprogesterone acetate (10 mg/d) or placebo, calendar days 16 to 25, with crossover.
Main Outcome Measures
Comparison of mean temperature days 17 to 26 during MPA versus placebo; comparison of differences between temperatures days 7 to 16 and 17 to 26 in MPA versus placebo months; and analysis for a significant monthly thermal shift.
Results
The mean temperatures during MPA treatment averaged 0.27 degrees C higher than during the placebo phase and showed a significant change from pretreatment to "treatment" phases during MPA but not during placebo cycles. Eight of the MPA and one of the placebo cycles showed a shift from lower to higher temperatures days 16 to 25.
Conclusions
Medroxyprogesterone acetate has a physiological progesterone-like thermal effect. Therefore basal temperature data cannot reliably indicate ovulation during cyclic MPA administration.
Prior JC medroxyprogesterone basal body temperature, MPA thermogenic effect postmenopausal women placebo controlled, basal temperature shift progesterone medroxyprogesterone acetate, ovulation detection reliability during MPA cyclic therapy, progestin thermal effect crossover trial, medroxyprogesterone acetate basal temperature postmenopausal, progesterone like thermal shift synthetic progestin, double blind crossover basal temperature progestogen, cyclic MPA administration ovulation determination limitation, Prior JC progesterone temperature regulation
PMID 7750591 7750591 DOI 10.1016/S0015-0282(16)57601-8 10.1016/S0015-0282(16)57601-8
Cite this article
Prior, J. C., McKay, D. W., Vigna, Y. M., & Barr, S. I. (1995). Medroxyprogesterone increases basal temperature: a placebo-controlled crossover trial in postmenopausal women. *Fertility and sterility*, *63*(6), 1222-1226. https://doi.org/10.1016/S0015-0282(16)57601-8
Prior, J. C., et al. "Medroxyprogesterone increases basal temperature: a placebo-controlled crossover trial in postmenopausal women." *Fertility and sterility*, vol. 63, no. 6, 1995, pp. 1222-1226.
Objective: To examine birth outcomes between children conceived with in vitro fertilization (IVF) or intrauterine insemination (IUI) and sibling births from unassisted conceptions.
Design: Retrospect...
Infertility > Assisted Reproductive Technology > IVF OutcomesPregnancy > Neonatal Outcomes > Birth Weight and Gestational AgeContraception/Comparison > ART vs Natural Conception > Sibling Studies
Objective: Disordered eating behaviors may impact the gynecologic health of adolescents through effects on menstrual cycle function and body size; however, few studies have evaluated these association...